XiaoMi-AI文件搜索系统
World File Search Systemcannot
Drdoctor碳减少计划
o与我们的供应商合作，鼓励他们测量，报告和减少自己的排放。可持续商务旅行o实施一项新政策，以减少旅行并支持更可持续的运输方式可持续通勤o实施新的政策，以减少通勤并鼓励使用更可持续的运输方式。我们还将扩展和增强我们的数据收集（包括深入通勤调查），以提高排放报告的精度。可持续的远程工作o实施新政策，以鼓励通过教育和家庭装修工具包（排除范围，散热器反射器等）的可持续家庭工作）可持续硬件o硬件硬件生命周期管理；调查硬件的可持续性，采购，管理和处置。包括选择设备/设备以及人们如何使用设备。 Reducing client emissions o Work with our clients to help reduce their carbon emissions by implementing digital appointments over in person appointments and digital letters/notifications over printed paper letters Improving data collection o We want to conduct more thorough data collection/measurements to get a more in-depth understanding of our carbon footprint Carbon removal credits o Where emissions cannot be reduced, we will seek to purchased high- quality carbon credits.
fortios 7.4.2发行说明
更改日志6介绍和支持的模型8支持的模型8 Fortigation 6000和7000支持8特殊通知9超大的不相容性和限制9 FortiGate 6000和7000不相容性和7000不相容性和限制9删除OCVPN支持9删除OCVPN支持9删除WTP配置文件9 Admin and super_admin administrators cannot log in after a prof_admin VDOM administrator restores the VDOM configuration and reboots the FortiGate 11 SMB drive mapping with ZTNA access proxy 11 Remote access with write rights through FortiGate Cloud 12 FortiGuard Web Filtering Category v10 update 12 FortiAP-W2 models may experience bootup failure during automatic firmware and federated upgrade process if they are powered by a managed FortiSwitch's PoE port 12 CLI系统权限13使用ECMP途径的本地流量可以使用不同的端口或服务器13 CLI的变化15 GUI行为的变化16违约行为的变化17表尺寸的变化17新功能或增强功能19 Cloud 6000和7000平台19 GUI 19 GUI 20 Hyperscale 20 Hyperscale 20 Hyperscale 20 Lan Edge 20 LAN Edge 21 Log＆Report
COVID-19-19S医学豁免表第二部分。 ...COVID-19-19S医学豁免表第二部分。 ...
Onondaga社区学院COVID -199疫苗接种要求医疗豁免请求模型第二部分。医疗豁免请求（由医疗提供者完成）持牌医疗提供者（医师，医师的助理或护士从业者），学生应审查有关COVID -19疫苗禁忌症的CDC指南。提供商必须填写第A和/或B节，并在C节中提供其提供者信息。Medical Provider Certification of Contraindication : I certify that my patient (named above) cannot be vaccinated against COVID‐19 because of the following contraindication: Please select which of the medically indicated COVID‐19 vaccine contraindications defined by the CDC apply: ☐ Severe allergic reaction (anaphylaxis) after a previous dose or to a component of the COVID‐19 Vaccine, including Polyethylene糖（钉）。（描述下面的反应/反应，以及对替代疫苗的禁忌症。）☐对先前剂量或已知（诊断）过敏的直接过敏反应对疫苗的成分。（描述下面的反应/反应以及替代疫苗的禁忌症）。Additional details on the selected option(s) above (to be completed by the medical provider): ____________________________________________________________________________________ ____________________________________________________________________________________ ____________________________________________________________________________________ ____________________________________________________________________________________ Please note that NONE of以下被认为是共vid -19疫苗的禁忌症。
18650 BMS 3S/4S 40A 60A LI-ION LITHIUM电池充电器保护板钻机11.1V 12.6V/14.8V 16.8V 16.8V增强/平衡
充电电压：DC 12.6V〜13.6V余额版本产品尺寸：41*61*4毫米增强版本产品尺寸：41*55*4mm连续充电电流：最多20A说明：连续放电当前：40A最大电流：最大耗散环境（如果热量耗散环境不好 18650, 26650, polymer lithium battery), can be drilled below 170W Note: 1: Successfully start the drill requires 3 10C-20C power batteries, or 6 5C-10C power batteries (recommended power battery models: sony vtc4, vtc4A, vtc5A, vtc6) OV and 12.6V cable, use Copper wire of 3 square millimeters or more (nickel sheets cannot be used) 2：根据图严格连接0V，4.2V，8.4V，12.6V。在焊接电线时，请勿触摸板上的任何组件。不要故意短路。3：在第一次焊接电池或进行充电时，只要单个电池超过4.2V，“ 430”电阻将加热并放电（放电到约4.19V以停止加热）。如果“ 430”电阻非常热，请检查错误的线是否连接。硬件准备：准备3S 12.6V 40A锂电池保护模块，电池，电源，高电源负载电阻
18650 BMS 3S/4S 40A 60A LI-ION LITHIUM电池充电器保护板钻机11.1V 12.6V/14.8V 16.8V 16.8V增强/平衡
充电电压：DC 12.6V〜13.6V余额版本产品尺寸：41*61*4毫米增强版本产品尺寸：41*55*4mm连续充电电流：最多20A说明：连续放电当前：40A最大电流：最大耗散环境（如果热量耗散环境不好 18650, 26650, polymer lithium battery), can be drilled below 170W Note: 1: Successfully start the drill requires 3 10C-20C power batteries, or 6 5C-10C power batteries (recommended power battery models: sony vtc4, vtc4A, vtc5A, vtc6) OV and 12.6V cable, use Copper wire of 3 square millimeters or more (nickel sheets cannot be used) 2：根据图严格连接0V，4.2V，8.4V，12.6V。在焊接电线时，请勿触摸板上的任何组件。不要故意短路。3：在第一次焊接电池或进行充电时，只要单个电池超过4.2V，“ 430”电阻将加热并放电（放电到约4.19V以停止加热）。如果“ 430”电阻非常热，请检查错误的线是否连接。硬件准备：准备3S 12.6V 40A锂电池保护模块，电池，电源，高电源负载电阻
Clinical trials of new drugs for Alzheimer disease
Alzheimer disease (AD) accounts for 60 – 70% of dementia cases. Given the seriousness of the disease and continual increase in patient numbers, developing effective therapies to treat AD has become urgent. Presently, the drugs available for AD treatment, including cholinesterase inhibitors and an antagonist of the N-methyl-D-aspartate receptor, can only inhibit dementia symptoms for a limited period of time but cannot stop or reverse disease progression. On the basis of the amyloid hypothesis, many global drug companies have conducted many clinical trials on amyloid clearing therapy but without success. Thus, the amyloid hypothesis may not be completely feasible. The number of anti-amyloid trials decreased in 2019, which might be a turning point. An in-depth and comprehensive understanding of the contribution of amyloid beta and other factors of AD is crucial for developing novel pharmacotherapies. In ongoing clinical trials, researchers have developed and are testing several possible interventions aimed at various targets, including anti-amyloid and anti-tau interventions, neurotransmitter modification, anti-neuroinflammation and neuroprotection interventions, and cognitive enhancement, and interventions to relieve behavioral psychological symptoms. In this article, we present the current state of clinical trials for AD at clinicaltrials.gov . We reviewed the underlying mechanisms of these trials, tried to understand the reason why prior clinical trials failed, and analyzed the future trend of AD clinical trials.
结核病的治疗和管理
治疗和管理•患有HIVºRIF的患者不应用于接受大多数抗HIV蛋白酶抑制剂（PIS）和非核苷逆转录酶抑制剂（NNRTIS）的患者。RFB；可能需要调整RFB剂量以同时给予某些抗HIV PI和NNRTIS。RIF可与核苷逆转录酶抑制剂（NRTIS）一起使用。请咨询专家。• RIPE treatment regimen º Doses should not be divided º Use EMB with caution in children whose vision cannot be monitored º Discontinue EMB when susceptibility to INH and RIF is demonstrated with good clinical response º Discontinue PZA after the Initial Phase - 8 weeks ( see treatment table for number of doses ) - unless there is resistance to either INH or RIF or lack of clinical response • Drug resistance º Mono-drug resistant disease可能需要改变治疗方案。寻求专家咨询。º多药抗性疾病（对INH和RIF的抗性）需要个性化的治疗方案并延长治疗。寻求专家咨询。•对肺结核患者的痰监测º进行至少每月进行痰液监测，直到连续2种持续的痰培养物变为阴性。ºEDOH建议与结核病专家咨询，以便在初始阶段结束时仍然是痰培养阳性的任何人。 •正在进行的评估ºEDOH建议与结核病专家咨询，以便在初始阶段结束时仍然是痰培养阳性的任何人。•正在进行的评估
发行说明-Fortios 7.2.4
Change Log 6 Introduction and supported models 9 Supported models 9 Special notices 10 IPsec phase 1 interface type cannot be changed after it is configured 10 IP pools and VIPs are not considered local addresses for certain FortiOS versions 10 Support for FortiGates with NP7 processors and hyperscale firewall features 10 Changes in CLI 11 Changes in GUI behavior 13 Changes in default behavior 14 Changes in default values 15 Changes in table size 16 New features or enhancements 17 Upgrade information 30 Fortinet Security Fabric upgrade 30 Downgrading to previous firmware versions 31 Firmware image checksums 32 Strong cryptographic cipher requirements for FortiAP 32 FortiGate VM VDOM licenses 32 VDOM link and policy configuration is lost after upgrading if VDOM and VDOM link have the same name 32 GUI firmware upgrade does not respect upgrade path 33 Product integration and support 34 Virtualization environments 35 Language support 35 SSL VPN支持36 SSL VPN Web模式36解决问题37反垃圾邮件37抗病毒37应用程序控制37数据泄漏预防38端点控制38显式代理38 FIREWALL 38 FORTIVIEW 40 GUI 40 HA 42 HYPERSCALE 42 HYPERSCALE 43 ICAP 44 ICAP 44
fortios 7.6.0发行说明
Change Log 6 Introduction and supported models 8 Supported models 8 FortiGate 6000 and 7000 support 8 Special notices 9 Hyperscale incompatibilities and limitations 9 FortiGate 6000 and 7000 incompatibilities and limitations 9 SSL VPN removed from 2GB RAM models for tunnel and web mode 9 2 GB RAM FortiGate models no longer support FortiOS proxy-related features 10 FortiGate VM memory and upgrade 10 Hyperscale NP7 hardware limitation 10 FortiGate cannot restore configuration file 10 Changes in CLI 12 Changes in GUI behavior 13 Changes in default behavior 14 Changes in table size 15 New features or enhancements 16 Cloud 16 GUI 16 LAN Edge 17 Log & Report 20 Network 21 Policy & Objects 26 SD-WAN 27 Security Fabric 28 Security Profiles 29 System 31 User & Authentication 34 VPN 34 ZTNA 35 Upgrade information 37 Fortinet Security Fabric upgrade 37 Downgrading to previous firmware版本39固件图像校验和39 FortiGate 6000和7000升级信息39 CP-ACCEL模式的默认设置2GB内存模型40产品集成和支持41虚拟化环境42语言支持42 SSL VPN VPN支持43
fortios 7.6.1发行说明
Change Log 6 Introduction and supported models 7 Supported models 7 FortiGate 6000 and 7000 support 7 Special notices 8 FortiManager support for updated FortiOS private data encryption key 8 FortiGate cannot restore configuration file after private-data-encryption is re-enabled 9 Hyperscale incompatibilities and limitations 10 FortiGate 6000 and 7000 incompatibilities and limitations 10 SSL VPN removed from 2GB RAM models for tunnel and Web模式10 2 GB RAM FortiGate模型不再支持与Fortios代理相关的功能10 FortiGate VM内存和升级11 Hyperscale NP7 NP7硬件限制11 GUI与IPSEC TCP在同一界面11 ssl VPN上的冲突不受IPSEC TCP的冲突。默认值19表尺寸20的变化20新功能或增强功能21云21 GUI 22 LAN EDGE 22网络22网络23策略与物体26 SD-WAN 27 SD-WAN 27安全织物30安全构造30安全配置文件30系统31用户和身份验证32 VPN 32 WIFI Controller 33 ZTNA 33 ZTNA 33升级信息33升级信息35 FortInet Security FaftInet Problade 35 FortInet diffore fort Grade diffore fort Grade difgrade to Grade difgrade difgrade difgrade difgrade 37